KIFC1 and cancer: Collectively, these above results demonstrate that KIFC1-S26 phosphorylation promotes the survival of cancer cells with extra centrosomes after treatment with etoposide, and this effect is inhibited by treatment with VE-822 both in vitro and in vivo.